Abstract P1-09-09: Role of endocrine therapy in premenopausal patients with hormone receptor-positive metastatic breast cancer, compared with postmenopausal patients: Diachronic analyses from nationwide cohort in Korea (KCSG BR 14-07)

Autor: G.M. Kim, Y.S. Chae, K.H. Lee, J-H Ahn, Y-H Im, T-Y Kim, Jae Ho Jeong, Young-Ae Park, Se Lee, KS Lee, S-J Koh, KH Park, Ke Lee, J.H. Kim, S-A Im, EK Cho, JH Yoon, Jung Ho Sohn, HS Won, KH Jung

Publikováno v: Cancer Research. 76:P1-09

Background Endocrine therapy (E) has a major role in treatment of hormone receptor (HR)-positive metastatic breast cancer (MBC). However, in contrast to western countries, premenopausal patients (PRE) more prevalent (50% of all breast cancer patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::80a0d7f60ae44c4ebd41d10b1324f025
https://doi.org/10.1158/1538-7445.sabcs15-p1-09-09

Study on Road Construction Technology of Low-lying and Swamp Area by Using Special Fine Sand

Autor: Ke Lee, Zheng Wu, Fei Yang

Publikováno v: Journal of Building Technology. 2:26

According to the site condition of one of the oversea project located in the low-lying and swamp area, special fine sand with fine modulus in values of 0.42-0.62 was used to construct roads in the area through special workmanship and construction tec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::56c5aae1cc2aac7e82c949eaf05d6c00
https://doi.org/10.32629/jbt.v2i1.169

429 Antiphospholipid antibody positivity and related clinical characteristics in korean lupus patients

Autor: SS Lee, Ke Lee, SK Cho, DJ Park, SW Nam, D Kim, YK Sung

Publikováno v: Poster Session.

Background and aims To identify the prevalence of positive antiphospholipid antibodies (aPL) and related clinical characteristics in Korean SLE patients Methods Among 505 SLE patients from KORean lupus NETwork (KORNET), we selected 469 patients who u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b1e65f13533a800385d1552e1838710
https://doi.org/10.1136/lupus-2017-000215.429

P3-16-06: Phase II Trial of TS-1 in Combination with Oxaliplatin (SOX) in Patients with Metastatic Breast Cancer (MBC) Previously Treated with Anthracycline and Taxane Chemotherapy [TORCH] [Korean Cancer Study Group (KCSG) BR07-03]

Autor: D-Y. Oh, S.-B. Kim, Keun Seok Lee, KS Lee, J Ro, J-H Ahn, S.-W. Han, B Keam, Min Hyuk Lee, Hyeoung-Joon Kim, Y-H. Im, S Kim, J.H. Kim, S-A Im, Ke Lee, H-S Park, J Shon, Joonghyun Ahn

Publikováno v: Cancer Research. 71:P3-16

Background Oxaliplatin, a platinum analogue, is an active drug in advanced anthracycline and taxane-pretreated breast cancer patients as a single agent and with 5-fluorouracil (5-FU) combination. TS-1 was developed by the scientific theory of both po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7535b15036e928c01ffae019464de7e9
https://doi.org/10.1158/0008-5472.sabcs11-p3-16-06

30th Annual Meeting • American Society of Preventive Oncology, Bethesda, Maryland • February 26–28, 2006

Autor: Amy Trentham-Dietz, Mario Alfaro, de González A Berrington, B Kreling, W Cao, Randa El-Zein, Karen Basen-Engquist, YC Yang, J Karp, Gammon, J Liao, Mark Schiffman, M. Concepcion Bratti, Susan E. Steck, KJ Cruickshanks, FF Zhang, Tim Byers, Susan M. Gapstur, Ruby T. Senie, Muhammad G. Kibriya, Philip E. Castle, Lisa A. Carey, Melissa L. Bondy, DK Chopin, V Reute, L Cai, Judith S. Jacobson, Mary Beth Terry, SA Varghese, HW Ressom, H Wallerand, Habibul Ahsan, HL Bradlow, Allan Hildesheim, Y An, Lorenzo Memeo, Sarah E. Lillie, DG Fryback, Joseph A. Galanko, Daniel W. Sepkovic, J. Hampton, Ana M. Rodriguez, Jeanne S. Mandelblatt, E Orvisky, Anne Marie Dyer, Marc Schwartz, J Heck, Janet B. Schoenberg, L Goldman, Michele Follen, Rachel T. Klein, Patricia A. Parker, Ke Lee, M Lee, W Liang, Brian L. Sprague, Michael E. Scheurer, Q Wang, L A Brinton, EC Dees, P Mai, M Knudtson, AB Troxel, M Abdel-Hamid, Suzanne C. O'Neill, R Goldman, Dawn L. Hershman, Y Chen, Philip Greenland, VR Grann, Melinda Butsch Kovacic, J Tooze, Temitope O. Keku, Regina M. Santella, Barbara K. Rimer, Robert D. Burk, Bek Klein, Noel T. Brewer, Lesley M. Butler, Mark E. Sherman, R DAgostino, Heather Greenlee, C Myers, Carlos Cordon-Cardo, ML Lu, Jorge Morales, JH Wang, Geoffrey C. Kabat, ZF Zhang, R Wang, Robert S. Sandler, Sholom Wacholder, Leslie R. Bernstein, Bc-H Chiu, H Hibshoosh, J Sullivan-Halley, S Moss, S. Sheinfeld Gorin, GL Hortin, Rolando Herrero, Irina Gurvich, R Sedjo, SK Drake, JJ Hu, Alfred I. Neugut, Mahesh Mansukhani, Jy Rao, Sand L. Pruitt, CA Loffredo

Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 15:408-412

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ad8d47021e1c02652d6c20b617f0def
https://doi.org/10.1158/1055-9965.epi-aspo-05